{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T21:30:23Z","timestamp":1785879023296,"version":"3.56.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T00:00:00Z","timestamp":1658880000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["MOST 111-2314-B-002-201-MY3"],"award-info":[{"award-number":["MOST 111-2314-B-002-201-MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["110-2314-B-002-030"],"award-info":[{"award-number":["110-2314-B-002-030"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ijid.2022.07.070","type":"journal-article","created":{"date-parts":[[2022,7,30]],"date-time":"2022-07-30T10:51:34Z","timestamp":1659178294000},"page":"1018-1025","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Clinical features and prognostic predictors in patients with rheumatic diseases complicated by Pneumocystis pneumonia"],"prefix":"10.1016","volume":"122","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7920-0341","authenticated-orcid":false,"given":"Yi-Min","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Hsun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiao-Feng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3218-0689","authenticated-orcid":false,"given":"Chieh-Yu","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song-Chou","family":"Hsieh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko-Jen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7718-0594","authenticated-orcid":false,"given":"Jung-Yien","family":"Chien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po-Ren","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2022.07.070_bib0001","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1080\/14397595.2018.1496873","article-title":"Rapid glucocorticoid tapering therapy to reduce mortality from pneumocystis pneumonia in patients with rheumatic disease","volume":"29","author":"Ando","year":"2019","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ijid.2022.07.070_bib0002","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1007\/s00296-009-0857-z","article-title":"Prognostic indicators related to death in patients with Pneumocystis pneumonia associated with collagen vascular diseases","volume":"29","author":"Aoki","year":"2009","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.ijid.2022.07.070_bib0003","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1007\/s10156-012-0441-4","article-title":"Early diagnosis and treatment are crucial for the survival of Pneumocystis pneumonia patients without human immunodeficiency virus infection","volume":"18","author":"Asai","year":"2012","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.ijid.2022.07.070_bib0004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0250611","article-title":"Prognostic impact of early adjunctive corticosteroid therapy in non-HIV oncology or haematology patients with Pneumocystis jirovecii pneumonia: A propensity score analysis","volume":"16","author":"Assal","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2022.07.070_bib0005","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1378\/chest.08-1309","article-title":"Polymerase chain reaction for diagnosing pneumocystis pneumonia in non-HIV immunocompromised patients with pulmonary infiltrates","volume":"135","author":"Azoulay","year":"2009","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2022.07.070_bib0006","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijid.2016.03.018","article-title":"Pneumocystis pneumonia suspected cases in 604 non-HIV and HIV patients","volume":"46","author":"Bienvenu","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2022.07.070_bib0007","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJM199011223232104","article-title":"A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. California Collaborative Treatment Group","volume":"323","author":"Bozzette","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.07.070_bib0008","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1007\/s10096-020-04118-w","article-title":"Characteristics and outcome according to underlying disease in non-AIDS patients with acute respiratory failure due to Pneumocystis pneumonia","volume":"40","author":"Burghi","year":"2021","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2022.07.070_bib0009","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nri.2017.1","article-title":"Immune regulation by glucocorticoids","volume":"17","author":"Cain","year":"2017","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.ijid.2022.07.070_bib0010","doi-asserted-by":"crossref","first-page":"792","DOI":"10.3899\/jrheum.090843","article-title":"A survey of rheumatologists\u2019 practice for prescribing pneumocystis prophylaxis","volume":"37","author":"Cettomai","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijid.2022.07.070_bib0011","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J Chronic Dis"},{"key":"10.1016\/j.ijid.2022.07.070_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2019.10.001","article-title":"Anidulafungin as an alternative treatment for Pneumocystis jirovecii pneumonia in patients who cannot tolerate trimethoprim\/sulfamethoxazole","volume":"55","author":"Chen","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2022.07.070_bib0013","doi-asserted-by":"crossref","first-page":"29","DOI":"10.2217\/fmb-2016-0115","article-title":"Evaluation of the automated Becton Dickinson MAX real-time PCR platform for detection of Pneumocystis jirovecii","volume":"12","author":"Chien","year":"2017","journal-title":"Future Microbiol"},{"key":"10.1016\/j.ijid.2022.07.070_bib0014","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1128\/JCM.00616-13","article-title":"Development and evaluation of a real-time PCR assay for detection of Pneumocystis jirovecii on the fully automated BD MAX platform","volume":"51","author":"Dalpke","year":"2013","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2022.07.070_bib0015","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/s13613-020-00649-9","article-title":"Adjunctive corticosteroids may be associated with better outcome for non-HIV Pneumocystis pneumonia with respiratory failure: a systemic review and meta-analysis of observational studies","volume":"10","author":"Ding","year":"2020","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijid.2022.07.070_bib0016","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1056\/NEJM199701233360402","article-title":"A prediction rule to identify low-risk patients with community-acquired pneumonia","volume":"336","author":"Fine","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.07.070_bib0017","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s13613-019-0604-x","article-title":"Outcome and prognostic factors of Pneumocystis jirovecii pneumonia in immunocompromised adults: a prospective observational study","volume":"9","author":"Gaborit","year":"2019","journal-title":"Ann Intensive Care"},{"key":"10.1016\/j.ijid.2022.07.070_bib0018","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.ijid.2022.07.070_bib0019","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1097\/QAD.0000000000002207","article-title":"Echinocandins as alternative treatment for HIV-infected patients with Pneumocystis pneumonia","volume":"33","author":"Huang","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2022.07.070_bib0020","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1086\/340867","article-title":"The impact of novel immunosuppressive agents on infections in organ transplant recipients and the interactions of these agents with antimicrobials","volume":"35","author":"Husain","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.07.070_bib0021","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ijid.2018.12.001","article-title":"Adjunctive corticosteroids decreased the risk of mortality of non-HIV Pneumocystis Pneumonia","volume":"79","author":"Inoue","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2022.07.070_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001508","article-title":"Estimation of treatment and prognostic factors of pneumocystis pneumonia in patients with connective tissue diseases","volume":"7","author":"Ishikawa","year":"2021","journal-title":"RMD Open"},{"key":"10.1016\/j.ijid.2022.07.070_bib0023","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.mayocp.2020.07.029","article-title":"Host Factors and outcomes in hospitalizations for Pneumocystis jirovecii pneumonia in the United States","volume":"96","author":"Kanj","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.ijid.2022.07.070_bib0024","article-title":"Clinical characteristics and prognosis of patients with Pneumocystis jirovecii pneumonia without a compromised illness","volume":"16","author":"Kim","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2022.07.070_bib0025","doi-asserted-by":"crossref","first-page":"S114","DOI":"10.1093\/cid\/ciaa1805","article-title":"Pneumocystis jirovecii disease: basis for the revised EORTC\/MSGERC invasive fungal disease definitions in individuals without human immunodeficiency virus","volume":"72","author":"Lagrou","year":"2021","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2022.07.070_bib0026","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.jmii.2019.05.003","article-title":"Pneumocystis jiroveci pneumonia in Taiwan from 2014 to 2017: clinical manifestations and outcomes between pediatric and adult patients","volume":"52","author":"Lee","year":"2019","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2022.07.070_bib0027","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1465-9921-14-87","article-title":"Adjunctive steroid in HIV-negative patients with severe Pneumocystis pneumonia","volume":"14","author":"Lemiale","year":"2013","journal-title":"Respir Res"},{"key":"10.1016\/j.ijid.2022.07.070_bib0028","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jmii.2012.08.024","article-title":"Pneumocystis jiroveci pneumonia in immunocompromised patients: delayed diagnosis and poor outcomes in non-HIV-infected individuals","volume":"47","author":"Li","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2022.07.070_bib0029","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.2147\/IDR.S199761","article-title":"Clinical characteristics, treatment outcomes, and prognostic factors of Pneumocystis pneumonia in non-HIV-infected patients","volume":"12","author":"Liu","year":"2019","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijid.2022.07.070_bib0030","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1016\/j.transproceed.2017.04.020","article-title":"Combination of echinocandins and trimethoprim\/sulfamethoxazole for the treatment of Pneumocystis jiroveci pneumonia after heart transplantation","volume":"49","author":"Lu","year":"2017","journal-title":"Transplant Proc"},{"key":"10.1016\/j.ijid.2022.07.070_bib0031","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1086\/513988","article-title":"Novel anti-Pneumocystis carinii effects of the immunosuppressant mycophenolate mofetil in contrast to provocative effects of tacrolimus, sirolimus, and dexamethasone","volume":"175","author":"Oz","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2022.07.070_bib0032","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1378\/chest.113.5.1215","article-title":"Use of adjunctive corticosteroids in severe adult non-HIV pneumocystis carinii pneumonia","volume":"113","author":"Pareja","year":"1998","journal-title":"Chest"},{"key":"10.1016\/j.ijid.2022.07.070_bib0033","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199001183220304","article-title":"The risk of pneumocystis carinii pneumonia among men infected with human immunodeficiency virus type 1. Multicenter AIDS Cohort Study Group","volume":"322","author":"Phair","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2022.07.070_bib0034","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/rheumatology\/keh071","article-title":"Detection of Pneumocystis carinii by DNA amplification in patients with connective tissue diseases: re-evaluation of clinical features of P. carinii pneumonia in rheumatic diseases","volume":"43","author":"Saito","year":"2004","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.ijid.2022.07.070_bib0035","doi-asserted-by":"crossref","first-page":"191","DOI":"10.3109\/s10165-005-0395-9","article-title":"Clinical characteristics of Pneumocystis carinii pneumonia in patients with connective tissue diseases","volume":"15","author":"Sato","year":"2005","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.ijid.2022.07.070_bib0036","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nrmicro1621","article-title":"Current insights into the biology and pathogenesis of Pneumocystis pneumonia","volume":"5","author":"Thomas","year":"2007","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.ijid.2022.07.070_bib0037","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1093\/rheumatology\/kes146","article-title":"Systemic lupus erythematosus disease activity Index 2000 Responder Index 50: sensitivity to response at 6 and 12 months","volume":"51","author":"Touma","year":"2012","journal-title":"Rheumatol (Oxford)"},{"key":"10.1016\/j.ijid.2022.07.070_bib0038","series-title":"Endocrinol Metabolism","first-page":"610","article-title":"Glucocorticoid therapy","author":"Tyrrell","year":"1995"},{"key":"10.1016\/j.ijid.2022.07.070_bib0039","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/art.21695","article-title":"Short-term prediction of mortality in patients with systemic lupus erythematosus: classification of outcomes using random forests","volume":"55","author":"Ward","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ijid.2022.07.070_bib0040","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1136\/annrheumdis-2017-212588","article-title":"Pneumocystis and glucocorticoid use: to prophylax or not to prophylax (and when?); that is the question","volume":"77","author":"Winthrop","year":"2018","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ijid.2022.07.070_bib0041","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jmii.2020.06.007","article-title":"Identifying predictors for bacterial and fungal coinfection on chest computed tomography in patients with Pneumocystis pneumonia","volume":"54","author":"Wu","year":"2021","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2022.07.070_bib0042","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jmii.2019.08.012","article-title":"Diagnosis of Pneumocystis pneumonia by real-time PCR in patients with various underlying diseases","volume":"53","author":"Yang","year":"2020","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/j.ijid.2022.07.070_bib0043","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00296-014-3073-4","article-title":"Pneumocystis jirovecii pneumonia in mycophenolate mofetil-treated patients with connective tissue disease: analysis of 17 cases","volume":"34","author":"Zhang","year":"2014","journal-title":"Rheumatol Int"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222004659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971222004659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T17:11:14Z","timestamp":1778519474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971222004659"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":43,"alternative-id":["S1201971222004659"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2022.07.070","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical features and prognostic predictors in patients with rheumatic diseases complicated by Pneumocystis pneumonia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2022.07.070","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}]}}